RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
Active, not recruiting · NCT03524430 · Registry updated 2026-05-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not applicable | 2026-05-28 | NCT03524430 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rna Diagnostics Inc. | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital U. 12 de Octubre | Madrid | Spain | 1 |
| Institut de Cancerologie de Strasbourg | Strasbourg | France | 1 |
| NZOZ Neuromed | Lublin | Poland | 1 |
| Siteman Cancer Center | St Louis | United States | 1 |
| SST di Cremona Multidisciplinare di Patologia Mammaria, Italy | Cremona | Italy | 1 |
| Sunnybrook Health Sciences Center | Toronto | Canada | 2 |
| Universitätsklinikum Münster | Münster | Germany | 23 |